This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alere Inc. Announces Hiring Of Namal Nawana As Chief Operating Officer

WALTHAM, Mass., Dec. 12, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company") announced today the appointment of Namal Nawana as its new Chief Operating Officer, effective December 30, 2012. Mr. Nawana comes to Alere from Johnson & Johnson, where he has spent 15 years in various leadership roles, spanning the fields of engineering, marketing, sales and general management, including in Canada, Europe, the United States and the Asia Pacific region. At Alere, Mr. Nawana will be responsible for all commercial, R&D and operational functions, globally.

Mr. Nawana's experience before and at Johnson & Johnson  has earned him a reputation as a strategist, an innovator and a global operations leader focused on scaling businesses profitably. Most recently, Mr. Nawana served as the Worldwide President of DePuy Synthes Spine, a Johnson & Johnson company, responsible for, among other things, managing all operations globally. Prior to that, he was Area Vice President for Johnson & Johnson Medical's operations in Australia and New Zealand, Chairman of the DePuy Asia Pacific Franchise Council, General Manager for DePuy Australia and General Manager for Depuy Canada. Through these roles, Mr. Nawana demonstrated a consistent track record of delivering year over year results.  During this time, Mr. Nawana was responsible for the planning and integration of numerous significant business acquisitions, and he played a key role in integrating the multi-billion dollar Synthes acquisition.

"Namal's extensive experience driving improvement and change within a global medical device manufacturer on the scale of DePuy Synthes Spine, and in particular his experience leading complex business integrations, fits perfectly with Alere's needs as worldwide provider of healthcare solutions which has experienced extraordinary growth through acquisitions," said Ron Zwanziger, Alere's Chief Executive Officer. "Namal's appointment demonstrates our commitment to improving execution at all levels. Just as important, Namal's visionary leadership and expertise in operational integration will aid Alere in delivering products which not only provide reliable diagnostics but also incorporate connectivity technologies that put patients in touch with caregivers on a real-time basis."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,862.48 +72.29 0.43%
S&P 500 1,986.33 +6.41 0.32%
NASDAQ 4,758.5070 +10.1460 0.21%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs